Cerdelga® (eliglustat) Capsules Official Patient Site
Welcome to the official patient site for Cerdelga®, the only first-line oral therapy indicated for the long-term treatment of most adults with Gaucher disease type 1. Get access to Cerdelga® support and resources. See risks and benefits.
Keywords:
genzyme logo, cerdelga, eliglustat, metabolizer status
Created: | 2012-05-25 |
Expires: | 2024-05-25 |
Owner: | Domain Names (Genzyme Corporation) |
Hosting company: | Amazon.com, Inc. |
Registrar: | CSC CORPORATE DOMAINS, INC. |
IPs: | 108.138.85.31, 108.138.85.37, 108.138.85.70, 108.138.85.72 |
DNS: |
ns1.sanofi-synthelabo.com ns2.sanofi-synthelabo.com ns3.sanofi-synthelabo.com ns4.sanofi-synthelabo.com |
Email: | See owner's emails |